Why the study?
Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality in patients with AMI or CHF?
Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality in patients with AMI or CHF?
ACE inhibitors reduce total mortality but not arrhythmic mortality in patients with heart failure, supporting their use as standard therapy.
No takes yet. Share an insight, caveat, or question.
Supports ACE inhibitor use for total mortality reduction in CHF; leaves open arrhythmia-specific interventions.
Naccarella et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: